Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

  1. Oliver-Caldés, A.
  2. González-Calle, V.
  3. Cabañas, V.
  4. Español-Rego, M.
  5. Rodríguez-Otero, P.
  6. Reguera, J.L.
  7. López-Corral, L.
  8. Martin-Antonio, B.
  9. Zabaleta, A.
  10. Inogés, S.
  11. Varea, S.
  12. Rosiñol, L.
  13. López-Díaz de Cerio, A.
  14. Tovar, N.
  15. Jiménez, R.
  16. López-Parra, M.
  17. Rodríguez-Lobato, L.G.
  18. Sánchez-Salinas, A.
  19. Olesti, E.
  20. Calvo-Orteu, M.
  21. Delgado, J.
  22. Pérez-Simón, J.A.
  23. Paiva, B.
  24. Prósper, F.
  25. Sáez-Peñataro, J.
  26. Juan, M.
  27. Moraleda, J.M.
  28. Mateos, M.-V.
  29. Pascal, M.
  30. Urbano-Ispizua, A.
  31. Fernández de Larrea, C.
  32. Show all authors +
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2023

Volume: 24

Issue: 8

Pages: 913-924

Type: Article

DOI: 10.1016/S1470-2045(23)00222-X GOOGLE SCHOLAR

Sustainable development goals